| 2701 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,1 |
| 2702 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,3 |
| 2703 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
4,7 |
| 2704 |
Cord Tissue |
Allogeneic – Unrelated |
Lack Of Expected Normal Physical Development |
Neurology |
2022 |
Experimental Therapy |
Poland |
7,5 |
| 2705 |
Cord Tissue |
Allogeneic – Unrelated |
Meniscus Damage |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
47,1 |
| 2706 |
Cord Tissue |
Allogeneic – Unrelated |
Meniscus Damage |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
22,11 |
| 2707 |
Cord Tissue |
Allogeneic – Unrelated |
Meniscus Damage |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
49,1 |
| 2708 |
Cord Tissue |
Allogeneic – Unrelated |
Meniscus Damage |
Orthopedy |
2022 |
Experimental Therapy |
Poland |
54,6 |
| 2709 |
Cord Tissue |
Allogeneic – Unrelated |
Muscular Dystrophy |
Neurology |
2022 |
Experimental Therapy |
Poland |
62,9 |
| 2710 |
Cord Tissue |
Allogeneic – Unrelated |
Myelomeningocele |
Neurology |
2022 |
Experimental Therapy |
Poland |
2,3 |
| 2711 |
Cord Tissue |
Allogeneic – Unrelated |
Myelomeningocele |
Neurology |
2022 |
Experimental Therapy |
Poland |
1,4 |
| 2712 |
Cord Tissue |
Allogeneic – Unrelated |
Optic Atrophy |
Ophthalmology |
2022 |
Experimental Therapy |
Poland |
25,7 |
| 2713 |
Cord Tissue |
Allogeneic – Unrelated |
Optic Atrophy |
Ophthalmology |
2022 |
Experimental Therapy |
Poland |
14,1 |
| 2714 |
Cord Tissue |
Allogeneic – Unrelated |
Optic Atrophy |
Ophthalmology |
2022 |
Experimental Therapy |
Poland |
26,1 |
| 2715 |
Cord Tissue |
Allogeneic – Unrelated |
Ovarian Dysfunction |
Gynecology |
2022 |
Experimental Therapy |
Poland |
37,11 |
| 2716 |
Cord Tissue |
Allogeneic – Unrelated |
Premature Ovarian Failure; Status After Oncological Treatment Of Breast Cancer |
Gynecology |
2022 |
Experimental Therapy |
Poland |
45,2 |
| 2717 |
Cord Tissue |
Allogeneic – Unrelated |
Sclerosis Multiplex |
Neurology |
2022 |
Experimental Therapy |
Poland |
41,3 |
| 2718 |
Cord Tissue |
Allogeneic – Unrelated |
Sequelae Of Spinal Cord Injury; Condition After A Spinal Cord Injury |
Neurology |
2022 |
Experimental Therapy |
Poland |
23,9 |
| 2719 |
Cord Tissue |
Allogeneic – Unrelated |
Spasmic Paralysis Of The Limbs |
Neurology |
2022 |
Experimental Therapy |
Poland |
33,9 |
| 2720 |
Cord Tissue |
Allogeneic – Unrelated |
Spastic Limb Paralysis |
Neurology |
2022 |
Experimental Therapy |
Poland |
30,11 |
| 2721 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2022 |
Experimental Therapy |
Poland |
12,11 |
| 2722 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2022 |
Experimental Therapy |
Poland |
20 |
| 2723 |
Cord Tissue |
Allogeneic – Unrelated |
Spinal Cord Injury |
Neurology |
2022 |
Experimental Therapy |
Poland |
39,11 |
| 2724 |
Cord Tissue |
Allogeneic – Unrelated |
Spinocerebellar Ataxia |
Neurology |
2022 |
Experimental Therapy |
Poland |
35,6 |
| 2725 |
Cord Blood |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
46 |
| 2726 |
Cord Blood |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2727 |
Cord Blood |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
2,5 |
| 2728 |
Cord Blood |
Autologous |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
7 |
| 2729 |
Cord Blood |
Autologous |
Autism |
Neurology |
2022 |
Experimental Therapy |
Hungary |
13 |
| 2730 |
Cord Blood |
Autologous |
Autism |
Neurology |
2022 |
Experimental Therapy |
Poland |
8,8 |
| 2731 |
Cord Blood |
Autologous |
Autism |
Neurology |
2022 |
Experimental Therapy |
Romania |
5 |
| 2732 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2022 |
Experimental Therapy |
UK |
11 |
| 2733 |
Cord Blood |
Allogeneic – Related |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Turkey |
19 |
| 2734 |
Cord Blood |
Autologous |
Hydrocephalus |
Neurology |
2022 |
Experimental Therapy |
Romania |
6 |
| 2735 |
Cord Blood |
Allogeneic – Related |
Sickle Cell Anemia |
Hematology |
2022 |
Standard Therapy |
Turkey |
7,7 |
| 2736 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2022 |
Standard Therapy |
Turkey |
19,2 |
| 2737 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2738 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2739 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2740 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2741 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2742 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
79 |
| 2743 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
23 |
| 2744 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2745 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2746 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
56 |
| 2747 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
46 |
| 2748 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2749 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2750 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
43 |
| 2751 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2752 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2753 |
Bone Marrow Family |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2754 |
Bone Marrow Family |
Allogeneic |
Blastic Plasmacytoid Dendritic Cell Neoplasm |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 2755 |
Bone Marrow Family |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2756 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2757 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia, Type 2 |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2758 |
Bone Marrow Family |
Allogeneic |
Leukocyte Adhesion Deficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
33 |
| 2759 |
Bone Marrow Family |
Allogeneic |
Mycosis Fungoides |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2760 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
71 |
| 2761 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 2762 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
29 |
| 2763 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 2764 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
71 |
| 2765 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2766 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2767 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis Post Essential Thrombocythemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2768 |
Bone Marrow Family |
Allogeneic |
Myeloma Multiplex |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2769 |
Bone Marrow Family |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
73 |
| 2770 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2771 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 2772 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2773 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2774 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2775 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
14 |
| 2776 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2777 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2778 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
38 |
| 2779 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2780 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2781 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2782 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
4 |
| 2783 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |
| 2784 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
8 |
| 2785 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2786 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
20 |
| 2787 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2788 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2789 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2790 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2791 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2792 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2793 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2794 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2795 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 2796 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
44 |
| 2797 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2798 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
75 |
| 2799 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
61 |
| 2800 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |